Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection

• Ngā kaituhi matua: Núria Climent (Author), Montserrat Plana (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Tyrosine kinase inhibitors (TKIs) of aberrant tyrosine kinase (TK) activity have been widely used to treat chronic myeloid leukemia (CML) for decades in clinic. An area of growing interest is the reported ability of TKIs to induce immunomodulatory effects with anti-tumor and anti-viral activity, whi...